A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Ukraine Hospital Improving Emergency Cardiovascular Care During National Crisis

Through ACC Global Quality Solutions Program, Dnipro hospital CV teams are enhancing skills and raising quality of care for local heart attack patients

The Clinical Hospital of Emergency Services, a municipal hospital serving the community of Dnipro, in Ukraine, is the first in the country to take part in the American College of Cardiology’s Global Quality Solutions program. The hospital in Ukraine joins the program in an effort to improve heart attack care by reducing heart attack related deaths and saving lives in their community.

“When the war started, myself and others on my team decided to stay at work to do our best to help our people, soldiers, neighbors and relatives to survive. But we decided it was not enough to only maintain, but that we must develop and raise our skills and quality of care,” said Anastasiya Skoromna, MD, PhD, Head of the Interventional Diagnostics and Percutaneous Treatment Department at the Clinical Hospital of Emergency Services in Dnipro, Ukraine. “Because, when the war ends, Ukraine will have a great need for the recovery of its systems and infrastructure. If we are ready, it will be an easier and faster recovery.”

ACC’s Global Quality Solutions program, in collaboration with Health Catalyst, works directly with hospitals around the world to collect data on cardiovascular procedures and identify specific opportunities to improve patient care and outcomes. As part of the program, the Clinical Hospital of Emergency Services will have access to data collection, analysis and reporting frameworks that leverage ACC’s NCDR CathPCI Registry data set.

According to the NCD Alliance, cardiovascular diseases account for 64% of all deaths from non-communicable diseases in Ukraine. This trend is compounded by the continued humanitarian crisis, which has displaced more than 12 million individuals of whom 2.63 million have cardiovascular disease.

“Ensuring access to essential cardiovascular care is more important than ever in Ukraine,” said ACC Immediate Past President Edward T.A. Fry, MD, MACC. “The Clinical Hospital of Emergency Services in Dnipro’s commitment to optimizing care and outcomes of patients with heart disease or related risk factors in the midst of unprecedented and unimaginable challenges—including a constant lack of supplies from basic syringes to interventional catheters and assist devices—is commendable, heroic and inspirational. It is truly an honor and privilege to support the hospital staff and clinicians in their quest to continue to transform cardiovascular care and improve heart health during this time.”

Skoromna’s team is made up of four interventional cardiologists ranging from newly practicing to longtime practitioners who are passionate about the work. The department opened at the end of 2021, shortly before the war began, making it even more difficult to start an interventional cardiology department where there hadn’t previously been one.

“The task was not only to start, but to integrate into the hospital system and then survive this war. We work 24/7 without weekends to provide care to our patients,” Skoromna said. “We have mostly acute coronary syndrome patients and late admissions. With such a diverse cohort of patients, being an interventional cardiologist is not enough. We need tools, supplies and what is most important—good and structured support.”

The Clinical Hospital of Emergency Services joins a growing list of hospitals around the world, including in South Africa, Brazil and Saudi Arabia, who are taking part in the Global Quality Solutions program and have a shared commitment to leveraging data and innovative technologies to proactively address the burden of cardiovascular disease within their own countries, as well as the rest of the world.

“Our hope is that by participating in the Global Quality Solutions program we will better be able to see the gaps in our care, so that we can learn how to deal with them and tune the health care system to work better,” Skoromna said. “The country worked for too long in post-Soviet order; we want and need to change it, once and forever, for the healthy future of our patients.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Dr. Sachita Shah, Sr. Director, Global Health, Butterfly Network, "Butterfly is proud to continue improving maternal health equity through Phase Two of the largest-scale handheld ultrasound distribution and training ever conducted in Sub-Saharan Africa. South Africa is an emerging market that continues to have disproportionately high rates of maternal mortality and stillbirth. Patients need easier access to antenatal imaging, and clinicians need better capabilities for screening high-risk conditions that lead to disproportionately worse pregnancy outcomes in rural areas in the public sector. Together with CHAI and GUSI, we can tackle this by making ultrasound much more accessible, so high-risk conditions can be identified earlier in care, which is known to improve outcomes.”
The clinical Study will enroll up to 97 patients at up to 12 European investigational sites. Completion of the study is expected this year, and results will support CE mark and pre-market approval submissions reports Vivasure Medical.
Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines
Leveraging the power of Apple Vision Pro to seamlessly blend digital content with the physical world Osso Health brings the operating experience to life via detailed, clinically accurate workflows of common procedures.

By using this website you agree to accept Medical Device News Magazine Privacy Policy